OncoResponse, Inc — Form D

OncoResponse, Inc of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-12. The offering totals $40.0M, of which $13.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Roberto A DePontiDirectorNone, N4
Steven A GillisDirectorChicago, IL
Wende A HuttonDirectorMenlo Park, CA
Ted A KoutouzisDirectorEvanston, IL
Robert J LechleiderExecutive OfficerSeattle, WA
Christopher A RussellExecutive OfficerSeattle, WA
Steve GillisDirectorNew York, NY
Steven GillisDirectorSouth San Francisco, CA
Andrew PerlmanDirectorAtlanta, GA
Geeta VemuriDirectorWaltham, MA
Sean A McCarthyDirectorHOUSTON, TX
Roberto D De PontiDirectorHOUSTON, TX
Alice J BexonExecutive OfficerHOUSTON, TX
Steven D GillisDirectorHOUSTON, TX
Clifford J StocksDirectorHOUSTON, TX
Clifford J StocksExecutive OfficerHOUSTON, TX
Kamal D PuriExecutive OfficerHOUSTON, TX
Carol D GallagherDirectorHOUSTON, TX
John A McKearnDirectorHOUSTON, TX
Chris D RussellExecutive OfficerHOUSTON, TX
Wende D HuttonDirectorHOUSTON, TX
TED KOUTOUZISDirectorSANTA CLARA, CA
Wende HuttonDirectorMenlo Park, CA
Clifford StocksDirectorHouston, TX
Clifford StocksExecutive OfficerHouston, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2025-05-06D$6.0M
2021-03-31D$60.0M$40.6M
2018-09-06D$40.0M$19.0M
2017-03-23D/A$34.0M$29.5M
2016-05-26D/A$28.2M$19.5M
2015-10-15D$28.2M$16.5M

More